SPL-IN-1
Product Specifications
UNSPSC Description
SPL-IN-1 (compound C17) is a dual species sphingosine-1-phosphate lyase inhibitor[1].
Target Antigen
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/spl-in-1.html
Solubility
10 mM in DMSO
Smiles
CCCOC(C1=C(SC2=C1CCCCC2)NC(CCCC(NC3=C(C4=C(S3)CCCCC4)C(OCCC)=O)=O)=O)=O
Molecular Weight
602.80
References & Citations
[1]Cellini B, et al. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study. Sci Rep. 2023;13(1):22692. Published 2023 Dec 20.
|[2]Cellini B, et al. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study. Sci Rep. 2023;13(1):22692. Published 2023 Dec 20.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163128/SPL-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163128/
Clinical Information
No Development Reported
CAS Number
353770-24-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items